SR9009 Capsules

Molecular Binding and Pathway Activation

SR9009 exhibits high lipophilicity (XLogP3-AA=4.4), enabling it to rapidly penetrate cell membranes and precisely bind to REV-ERBα (IC50=670 nM) and REV-ERBβ (IC50=800 nM). It induces conformational changes in receptors, recruits the NCoR/HDAC3 co-repressor complex, binds to the RORE element in the promoter region of target genes, and inhibits the transcription of core clock genes (e.g., Bmal1) and metabolic synthesis genes (e.g., Srebf1, Fasn), thereby synchronously regulating the whole-body metabolic network.

Mitochondrial Function Enhancement (Core Effect)

Upon activation of the REV-ERB pathway, SR9009 markedly promotes mitochondrial biogenesis in skeletal muscle and the liver, increases mitochondrial quantity and density, and improves the efficiency of mitochondrial oxidative phosphorylation. Meanwhile, it eliminates damaged mitochondria and reduces the accumulation of reactive oxygen species (ROS). This effect directly mimics the mitochondrial activation induced by aerobic exercise, boosting cellular energy output without actual high-intensity physical activity - serving as the core mechanism behind its reputation as exercise in a bottle.

Synchronization of Circadian Rhythm and Metabolism

REV-ERB acts as a bridge molecule linking circadian rhythm and metabolism. By regulating the expression of core clock genes in the hypothalamus, SR9009 corrects disrupted circadian rhythms and synchronizes metabolic rhythms in the liver, muscles and adipose tissues. It precisely matches energy consumption, lipid synthesis, glucose utilization and other physiological processes with the circadian cycle, preventing metabolic imbalance.

Improved Endurance and Athletic Performance: Mitochondria-Driven Endurance Multiplication

One of the most prominent properties of SR9009 is its ability to boost endurance and exercise performance without physical training, making it a key research focus for endurance athletes and fitness enthusiasts.

Breaking endurance limits: By increasing skeletal muscle mitochondrial quantity and oxidative efficiency, it elevates maximal oxygen uptake (VO2 max) and delays exercise-induced fatigue.

In animal trials, treadmill endurance in mice increased by over 50% with a notable extension of exercise duration.

Optimized energy efficiency: It shifts muscle energy preference to fat utilization, reduces glycogen consumption, prolongs high-intensity exercise duration, accelerates post-exercise glycogen recovery and shortens the recovery cycle, making it suitable for high-intensity interval training and endurance sports.

Muscle protection and recovery: It reduces the release of exercise-induced inflammatory factors (e.g., TNF-α, IL-6), alleviates exercise-induced muscle micro-damage and soreness, promotes muscle repair, lowers the risk of overtraining, and indirectly supports muscle maintenance and functional improvement.

Unlike traditional sports supplements that directly stimulate muscle growth, SR9009 naturally enhances athletic ability and recovery efficiency by optimizing energy metabolism and mitochondrial function, catering to demands for endurance improvement rather than muscle hypertrophy.

Therapeutic Potential for Metabolic Diseases: Obesity, Type 2 Diabetes and Metabolic Syndrome

Given its core regulatory role in metabolism, SR9009 holds significant value in preclinical research of metabolic diseases and provides a novel therapeutic target for obesity, type 2 diabetes, metabolic syndrome and other disorders.

Obesity and metabolic syndrome: It reverses obesity-induced metabolic disorders via fat reduction, blood lipid improvement, hypoglycemic effects and enhanced insulin sensitivity, lowers the risk of hepatic steatosis (fatty liver), and ameliorates core indicators of metabolic syndrome.

Type 2 diabetes: It promotes glucose utilization in the liver and muscles, inhibits hepatic gluconeogenesis, reduces fasting blood glucose and glycated hemoglobin levels, improves pancreatic β-cell function and lessens insulin dependence, offering a new non-insulin-dependent intervention strategy for type 2 diabetes.

Cardiometabolic protection: It reduces serum triglycerides and low-density lipoprotein cholesterol (bad cholesterol), raises high-density lipoprotein cholesterol (good cholesterol), lowers the risk of atherosclerosis, alleviates vascular endothelial inflammation and protects cardiovascular function.

Other Potential Effects: Anti-Inflammation, Anti-Tumor and Rhythm Regulation

Anti-inflammatory activity: It inhibits the NF-κB inflammatory pathway, reduces the release of inflammatory factors and relieves systemic inflammation, exerting tissue-protective effects in inflammatory models such as cardiac injury and arthritis.

Anti-tumor potential: It suppresses the proliferation of tumor cells including prostate cancer, small cell lung cancer and multiple myeloma by inhibiting autophagy and inducing tumor cell cycle arrest.

Combined with chemotherapeutic agents, it enhances anti-tumor sensitivity and provides a new strategy for tumor therapy.

Amelioration of circadian rhythm disorders: It corrects circadian disruption caused by staying up late, shift work and insomnia, improves sleep quality, regulates appetite and relieves fatigue, addressing circadian imbalance in modern populations.